Acceleron Pharma, Inc.

MA · United States · Reporting entity ID 100000776816

Total reported 2019–2025

$601K

#1,494 of 2,960 reporting companies — 0% of all reported industry payments

$335K in general payments across 1,668 records, plus $267K in research funding across 73 records.

How it breaks down

General payments $334,572

Research funding $266,809

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.